Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Talphera Inc (TLPH)

Talphera Inc (TLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,924
  • Shares Outstanding, K 50,050
  • Annual Sales, $ 30 K
  • Annual Income, $ -14,290 K
  • EBIT $ -13 M
  • EBITDA $ -14 M
  • 60-Month Beta 0.56
  • Price/Sales 1,335.08
  • Price/Cash Flow N/A
  • Price/Book 2.04
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.06 on 03/23/26
  • Next Earnings Date 05/13/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 389.22% (-84.02%)
  • Historical Volatility 91.73%
  • IV Percentile 47%
  • IV Rank 25.87%
  • IV High 1,215.52% on 04/28/25
  • IV Low 100.85% on 09/05/25
  • Expected Move (DTE 15) 0.0425 (5.46%)
  • Put/Call Vol Ratio 4.00
  • Today's Volume 50
  • Volume Avg (30-Day) 130
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 6,323
  • Open Int (30-Day) 18,490
  • Expected Range 0.7352 to 0.8202

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.15
  • Growth Rate Est. (year over year) +666,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7016 +10.85%
on 03/24/26
0.9400 -17.27%
on 03/04/26
-0.1339 (-14.69%)
since 02/27/26
3-Month
0.7016 +10.85%
on 03/24/26
1.2900 -39.71%
on 01/07/26
-0.3623 (-31.78%)
since 12/31/25
52-Week
0.3800 +104.66%
on 07/14/25
1.5700 -50.46%
on 11/24/25
+0.2477 (+46.74%)
since 04/01/25

Most Recent Stories

More News
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

SAN MATEO, Calif. , March 25, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...

TLPH : 0.7777 (+4.12%)
Talphera: Q4 Earnings Snapshot

Talphera: Q4 Earnings Snapshot

TLPH : 0.7777 (+4.12%)
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Previously announced achievement of 50% enrollment of the NEPHRO CRRT clinical study in March 2026 and closed the associated financing tranche of $4.1 million

TLPH : 0.7777 (+4.12%)
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

SAN MATEO, Calif. , March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...

TLPH : 0.7777 (+4.12%)
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new target profile sites

TLPH : 0.7777 (+4.12%)
Talphera: Q3 Earnings Snapshot

Talphera: Q3 Earnings Snapshot

TLPH : 0.7777 (+4.12%)
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc.

TLPH : 0.7777 (+4.12%)
CRMD : 7.02 (+3.39%)
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

SAN MATEO, Calif. , Nov. 5, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...

TLPH : 0.7777 (+4.12%)
Talphera Announces the Appointment of Joe Todisco to Board of Directors

SAN MATEO, Calif. , Oct. 21, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), (Talphera), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...

TLPH : 0.7777 (+4.12%)
CRMD : 7.02 (+3.39%)
CorMedix Announces Strategic Minority Investment in Talphera

BERKELEY HEIGHTS, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...

TLPH : 0.7777 (+4.12%)
CRMD : 7.02 (+3.39%)

Business Summary

Talphera Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate consists Niyad(TM). Talphera Inc., formerly known as AcelRx Pharmaceuticals Inc., is based in SAN MATEO,...

See More

Key Turning Points

3rd Resistance Point 0.8483
2nd Resistance Point 0.8231
1st Resistance Point 0.8004
Last Price 0.7777
1st Support Level 0.7525
2nd Support Level 0.7273
3rd Support Level 0.7046

See More

52-Week High 1.5700
Fibonacci 61.8% 1.1154
Fibonacci 50% 0.9750
Fibonacci 38.2% 0.8346
Last Price 0.7777
52-Week Low 0.3800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.